ArticleBriefings in bioinformatics2025
Ensemble learning methods and heterogeneous graph network fusion: building drug-gene-disease triple association prediction models.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential association data between drugs, genes, and diseases is sparse and complex. Existing models find it difficult to effectively handle the problem of heterogeneous relationships and multi-source data fusion simultaneously, resulting in limited accuracy and generalization of association prediction. To address this problem, we propose a fusion method of relational graph convolutional network (R-GCN) and eXtreme Gradient Boosting (XGBoost). First, a heterogeneous graph containing drug, gene, and disease nodes and their relationships is constructed. The features of different types of nodes are aggregated and represented by R-GCN to generate high-quality node embeddings. Then, the embedded features of the drug-gene-disease triples are input into the XGBoost model for training to achieve the association prediction task. The findings demonstrate that the model's area under the curve reaches 0.92, and the F1 score reaches 0.85, indicating strong predictive ability. This method solves the problem of association prediction in complex biological networks and brings new technological support for precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.